Evidence map›Paper›PMID 24799627›Full record

ArticleInfection and immunity2014

Identification and characterization of a peculiar vtx2-converting phage frequently present in verocytotoxin-producing Escherichia coli O157 isolated from human infections.

Rosangela Tozzoli, Laura Grande, Valeria Michelacci, Rosa Fioravanti, David Gally, Xuefang Xu, Roberto La Ragione, Muna Anjum, Guanghui Wu, Alfredo Caprioli and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Intestinal Carriage of Two DistinctPathogens (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Bacteriophages of Shiga Toxin-ProducingPathogens (Basel, Switzerland) · 2021
    Review
  4. Comparative Whole Genome Analysis ofFrontiers in microbiology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Rosangela TozzoliEU Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy rosangela.tozzoli@iss.it.
Laura GrandeEU Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy.
Valeria MichelacciEU Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy.
Rosa FioravantiEU Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy.
David GallyImmunity and Infection Division, Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.
Xuefang XuImmunity and Infection Division, Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.
Roberto La RagioneDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Weybridge, Addlestone, Surrey, United Kingdom School of Veterinary Medicine, University of Surrey, Guildford, Surrey, United Kingdom.
Muna AnjumDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Weybridge, Addlestone, Surrey, United Kingdom.
Guanghui WuDepartment of Bacteriology and Food Safety, Animal Health and Veterinary Laboratories Agency, Weybridge, Addlestone, Surrey, United Kingdom.
Alfredo CaprioliEU Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy.
Stefano MorabitoEU Reference Laboratory for Escherichia coli, Istituto Superiore di Sanità, Rome, Italy.
Istituto Superiore di Sanità · ITAnimal and Plant Health Agency · GBRoslin Institute · GBUniversity of Edinburgh · GBUniversity of Surrey · GB

Funding

Wellcome Trust 095831
6 · The paper itself

Abstract

Certain verocytotoxin-producing Escherichia coli (VTEC) O157 phage types (PTs), such as PT8 and PT2, are associated with severe human infections, while others, such as PT21, seem to be restricted to cattle. In an attempt to delve into the mechanisms underlying such a differential distribution of PTs, we performed microarray comparison of human PT8 and animal PT21 VTEC O157 isolates. The main differences observed were in the vtx2-converting phages, with the PT21 strains bearing a phage identical to that present in the reference strain EDL933, BP933W, and all the PT8 isolates displaying lack of hybridization in some regions of the phage genome. We focused on the region spanning the gam and cII genes and developed a PCR tool to investigate the presence of PT8-like phages in a panel of VTEC O157 strains belonging to different PTs and determined that a vtx2 phage reacting with the primers deployed, which we named Φ8, was more frequent in VTEC O157 strains from human disease than in bovine strains. No differences were observed in the production of the VT2 mRNA when Φ8-positive strains were compared with VTEC O157 possessing BP933W. Nevertheless, we show that the gam-cII region of phage Φ8 might carry genetic determinants downregulating the transcription of the genes encoding the components of the type III secretion system borne on the locus of enterocyte effacement pathogenicity island.

Indexed as

AnimalsCattleCattle DiseasesColiphagesDNA, ViralEscherichia coli InfectionsEscherichia coli O157Genome, ViralGenotypeHumansItalyOligonucleotide Array Sequence AnalysisShiga Toxin 2DNA, ViralShiga Toxin 2verocytotoxin 2

Identifiers

PMID24799627
PMCPMC4097640
OpenAlexW2148664518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.